Cyprus Mail
BritainWorld

UK approves Regeneron/Roche antibody cocktail to treat and prevent Covid-19

people queue to receive a dose of the pfizer biontech vaccine at an nhs vaccination centre hosted at the heaven nightclub in london
The MRHA said Ronapreve is not intended to be used as a substitute for vaccination REUTERS/Henry Nicholls

The UK’s health regulator has approved an antibody cocktail developed by Regeneron and Roche to prevent and treat COVID-19, it said on Friday, adding it was trying to roll it out to patients soon.

The Medicines and Healthcare products Regulatory Agency (MHRA) said the drug Ronapreve could help prevent infection, help resolve symptoms of severe COVID-19 infection and reduce the chances of hospitalisation.

“This treatment will be a significant addition to our armoury to tackle COVID-19,” British health minister Sajid Javid said in a statement.

Ronapreve can be taken via injection or infusion. It binds tightly to the coronavirus at the lining of the respiratory system and prevents it from gaining access to cells of the respiratory system, the MHRA said.

Ronapreve belongs to a class of drugs called monoclonal antibodies which mimic natural antibodies produced by the body to fight off infections. The drug is not intended to be used as a substitute for vaccination, the MHRA said.

Last month Japan became the first country to approve Ronapreve to treat mild to moderate COVID-19 infections.

Follow the Cyprus Mail on Google News

Related Posts

Pugacheva, queen of Soviet pop, likely to be labelled a ‘foreign agent’ in Russia

Reuters News Service

Illness, scandal and discord leave UK royal family looking depleted

Reuters News Service

Philippines’ Catholic devotees nailed to crosses to re-enact crucifixion

Reuters News Service

Israel strikes Syria hard

Reuters News Service

Kyiv’s top general says Ukraine needs fewer troops than expected

Reuters News Service

Nigeria to free 313 suspected Boko Haram insurgents for lack of evidence

Reuters News Service